Nov
08
Goldman Joins Valeant Sellers to Recoup Loan to CEO Pearson
By-
1.3 million shares were collateral for $100 million in loans
-
Deal financed Duke gift, swimming pool, share purchases, taxes
Add Goldman Sachs Group Inc. to the growing list of sellers of Valeant Pharmaceuticals International Inc.’s stock.
The drugmaker said Friday that the New York-based bank unloaded 1.3 million shares of Valeant, which it held as collateral against $100 million in personal loans to Valeant’s chief executive officer, Mike Pearson. The money will be used to repay the loans, which financed gifts to Pearson’s alma mater, Duke University, and funded a community swimming pool, stock purchases and tax payments…